About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Arbitration Award Issued
November 12, 2018
Click here to read more
Post navigation
Previous Post
Receipt of R&D Tax Incentive
Next Post
Receipt of R&D Tax Incentive
Related Posts
Phosphagenics Signs Japanese License Option Agreement for TPM Oxycodone Patch
May 17, 2016
Phosphagenics Signs Development Agreement for TPM Oxymorphone Patch in Japan
August 22, 2017
Avecho’s Phase III Clinical Trial for Insomnia Commences
March 26, 2024
March 26, 2024